Biotechnology - Pharmaceutical, Research

Filter

Current filters:

PharmaceuticalResearch

Popular Filters

1 to 25 of 383 results

Joint position to grow Australia's biopharmaceutical industry

Joint position to grow Australia's biopharmaceutical industry

29-05-2014

Trade groups AusBiotech and Medicines Australia this morning published a joint statement sent to the…

AustraliaBiotechnologyFinancialMarkets & MarketingPatentsPharmaceuticalResearch

Faster, better, safer: How clinical trials can be transformed by Equivital wearable technology

Faster, better, safer: How clinical trials can be transformed by Equivital wearable technology

04-02-2014

A UK-based mobile human monitoring company is making waves in health care as it aims to revolutionize…

BiotechnologyInterviewsPharmaceuticalResearchUK

US drug approvals lower than previously reported; new study

10-01-2014

The overall success rate for drugs moving through clinical trials to US Food and Drug Administration…

BiotechnologyNorth AmericaPharmaceuticalRegulationResearchUSA

What does the future hold for pharma?

What does the future hold for pharma?

22-11-2013

Here's our take on the week's top stories.

AstraZenecaBayerBiotechnologyCerulean PharmaMarkets & MarketingPharmaceuticalResearchSanofi

Sanofi’s alirocumab monotherapy reduced LDL cholesterol three times more than ezetimibe

Sanofi’s alirocumab monotherapy reduced LDL cholesterol three times more than ezetimibe

16-10-2013

Sanofi and partner Regeneron Pharmaceuticals this morning released results from the Phase III ODYSSEY…

BiotechnologyCardio-vascularPharmaceuticalRegeneronResearchSanofi

Mayor of London Boris Johnson praises UK's bioscience industry

Mayor of London Boris Johnson praises UK's bioscience industry

10-10-2013

Boris Johnson, the Mayor of London, addressed delegates at the UK Bioscience Forum this morning, telling…

BiotechnologyEuropePharmaceuticalResearch

Leaked Commission research documents raise questions about whose interests are being prioritized

08-10-2013

Scientists, public health researchers and non-governmental organizations have reacted with concern to…

BiotechnologyEuropeHealthcarePharmaceuticalPoliticsResearch

Vectura and UCB to collaborate on severe inflammatory disease

Vectura and UCB to collaborate on severe inflammatory disease

30-09-2013

Vectura and UCB have entered into a collaboration for the development of an innovative biologic immuno-modulatory…

BiotechnologyEuropeInflammatory diseasesPharmaceuticalResearchRespiratory and PulmonaryUCBVectura

Approved cancer drug potentially could help treat diabetes, Stanford researchers find

16-09-2013

A pair of studies by researchers at the Stanford University School of Medicine has identified a molecular…

afliberceptBayerBiotechnologyDiabetesEyleaOncologyPharmaceuticalRegeneronResearchSanofiZaltrap

Clinical study failures vary widely by clinical phase of and therapeutic class; study

11-09-2013

While lack of commercial viability is the leading cause of Phase I clinical trial failures for new drug…

BiotechnologyPharmaceuticalResearch

Novartis links with Regenerex in cell therapy research collaboration

06-09-2013

Swiss drug major Novartis (NOVN: VX) has entered into an exclusive global licensing and research collaboration…

BiotechnologyCTL019HSC835ImmunologicalsLicensingNovartisPharmaceuticalRegenerexResearch

Kyowa Hakko Kirin collaborates with Ultragenyx on KRN23

06-09-2013

Japanese mid-sized drugmaker Kyowa Hakko Kirin (TYO: 4151) has entered into a collaboration and license…

BiotechnologyKRN23Kyowa Hakko KirinLicensingPharmaceuticalRare diseasesResearchUltragenyx

GlaxoSmithKline's cancer drug candidate fails endpoint in melanoma

05-09-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) and partner US biotech firm Agenus (Nasdaq: AGEN) this morning…

AgenusBiotechnologyGlaxoSmithKlineMAGE-A3OncologyPharmaceuticalResearchVaccines

Further highlights from European Society of Cardiology meeting

03-09-2013

The ongoing European Society of Cardiology meeting in Amsterdam, Netherlands, continues to produce both…

ActelionalogliptinAmgenBiotechnologyCardio-vascularCytokineticsDiabetesomecamtiv mecarbilOpsumitPharmaceuticalResearchRespiratory and PulmonaryTakeda Pharmaceuticals

Positive results with Roche's dry-AMD drug candidate

28-08-2013

Swiss drug major Roche (ROG: SIX) has announced positive results from the Phase II MAHALO study showing…

BiotechnologylampalizumabOphthalmicsPharmaceuticalResearchRoche

Shire and Santaris extend strategic alliance

23-08-2013

Danish privately held clinical-stage biopharmaceutical company Santaris Pharma says that its long term…

BiotechnologyLicensingPharmaceuticalRare diseasesResearchSantaris PharmaShire

Eli Lilly's investigational sNSCLC drug meets Ph III endpoint

14-08-2013

US drug major Eli Lilly's (NYSE: LLY) shares rose nearly 4% to $56.21in pre-market trading when the company…

BiotechnologyBristol-Myers SquibbEli LillynecitumumabOncologyPharmaceuticalResearch

Dainippon Sumitomo establishes regenerative and cellular medicine office

12-08-2013

Japanese drug major Dainippon Sumitomo Pharma (TYO: 4506) says that it has set up the Regenerative &…

Asia-PacificBiotechnologyDainippon Sumitomo PharmaPharmaceuticalProductionResearch

GSK launches $50 million VC fund to invest in pioneering bioelectronic medicines and technologies

08-08-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) today (August 8) announced the launch of Action Potential…

BiotechnologyFinancialGlaxoSmithKlinePharmaceuticalResearchSetPoint Medical

Eylea meets primary endpoint in Ph III DME study

06-08-2013

German pharma major Bayer (BAYN: DE) revealed this morning (August 6) that, in the Phase III VIVID-DME…

BayerBiotechnologyEyleaOphthalmicsPharmaceuticalRegeneronResearch

Bionomics in $172 million pain treatment deal with US pharma giant

01-08-2013

Australian biotech firm Bionomics (ASX: BNO) has entered an agreement with US pharma giant Merck & Co…

BionomicsBiotechnologyLicensingMerck & CoNeurologicalPharmaceuticalResearch

Teijin and Amgen join forces on autoimmune disease research

31-07-2013

Japan's Teijin Pharma, the core company of the Teijin Group's (TSE: 3401) health care business, has entered…

AmgenBiotechnologyImmunologicalsInflammatory diseasesLicensingPharmaceuticalResearchTeijin

1 to 25 of 383 results

Back to top